Product: Tri-Moxi+¿  (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
Reason for recall: Presence of particulate matter - Glass like particles.
Recall initiated: 20251218
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated